Wooree Bio Co.Ltd (082850) — Capital Reinvestment Ratio
Wooree Bio Co.Ltd (082850) has a Capital Reinvestment Ratio of 0.09x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩33.98 Billion) in capital expenditures (₩3.07 Billion). Check Wooree Bio Co.Ltd (082850) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Wooree Bio Co.Ltd Capital Reinvestment Ratio (2008–2025)
This chart tracks Wooree Bio Co.Ltd's Capital Reinvestment Ratio across 15 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Wooree Bio Co.Ltd.
Annual Capital Reinvestment Ratio for Wooree Bio Co.Ltd (2008–2025)
Year-by-year Capital Reinvestment Ratio for Wooree Bio Co.Ltd from 2008 to 2025. See Wooree Bio Co.Ltd (082850) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.64x | ₩34.82 Billion | ₩22.42 Billion | ▼ -72.1% |
| 2024 | 2.31x | ₩36.24 Billion | ₩83.57 Billion | ▲ +452.5% |
| 2023 | 0.42x | ₩26.51 Billion | ₩11.07 Billion | ▲ +34.8% |
| 2022 | 0.31x | ₩43.35 Billion | ₩13.42 Billion | ▲ +33.8% |
| 2021 | 0.23x | ₩50.21 Billion | ₩11.62 Billion | ▼ -6.9% |
| 2020 | 0.25x | ₩69.43 Billion | ₩17.26 Billion | ▼ -32.2% |
| 2019 | 0.37x | ₩65.80 Billion | ₩24.11 Billion | ▼ -85.9% |
| 2018 | 2.59x | ₩10.82 Billion | ₩28.04 Billion | ▲ +115.2% |
| 2017 | 1.20x | ₩27.73 Billion | ₩33.37 Billion | ▲ +16.1% |
| 2014 | 1.04x | ₩54.31 Billion | ₩56.29 Billion | ▼ -18.2% |
| 2013 | 1.27x | ₩80.75 Billion | ₩102.35 Billion | ▼ -75.3% |
| 2011 | 5.12x | ₩8.36 Billion | ₩42.84 Billion | ▲ +9.2% |
| 2010 | 4.69x | ₩17.33 Billion | ₩81.28 Billion | ▲ +666.2% |
| 2009 | 0.61x | ₩46.60 Billion | ₩28.53 Billion | ▲ +5.1% |
| 2008 | 0.58x | ₩69.27 Billion | ₩40.36 Billion | — |